Some Zoonotic Antigens May Help Combat Unknown Pathogens: Forming the Puzzle from the Evidences in the COVID Era

Anwesha      Sahu; Tuhin      Mukherjee; Satyajit      Mohanty

doi:10.2174/0118715265301701240416055502

Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.

[1]
Temmam S, Barbarino A, Maso D, et al. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus. One Health  2020; 10: 100164.
 [http://dx.doi.org/10.1016/j.onehlt.2020.100164] [PMID:  32904469]

[2]
National Institutes of Health Llama antibody engineered to block coronavirus 2020. Available fromhttps://www.nih.gov/news-events/nih-research-matters/llama-antibody-engineered-block-coronavirus

[3]
Villanueva-Saz S, Giner J, Fernández A, et al. Absence of SARS-CoV-2 antibodies in natural environment exposure in sheep in close contact with humans. Animals  2021; 11(7): 1984.
 [http://dx.doi.org/10.3390/ani11071984] [PMID:  34359111]

[4]
Bhattacharya M, Chatterjee S, Lee SS, Chakraborty C. Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update. Int J Biol Macromol  2023; 229: 70-80.
 [http://dx.doi.org/10.1016/j.ijbiomac.2022.12.284] [PMID:  36586649]

[5]
Xu J, Xu K, Jung S, et al. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature  2021; 595(7866): 278-82.
 [http://dx.doi.org/10.1038/s41586-021-03676-z] [PMID:  34098567]

[6]
Botosso VF, Jorge SAC, Astray RM, et al. Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Sci Rep  2022; 12(1): 3890.
 [http://dx.doi.org/10.1038/s41598-022-07793-1] [PMID:  35273234]

[7]
Ekstrand K, Flanagan AJ, Lin IE, et al. Animal transmission of SARS-CoV-2 and the welfare of animals during the COVID-19 pandemic. Animals  2021; 11(7): 2044.
 [http://dx.doi.org/10.3390/ani11072044] [PMID:  34359172]

[8]
Mastutik G, Rohman A, I’tishom R, Ruiz-Arrondo I, de Blas I. Experimental and natural infections of severe acute respiratory syndrome-related coronavirus 2 in pets and wild and farm animals. Vet World  2022; 15(3): 565-89.
 [http://dx.doi.org/10.14202/vetworld.2022.565-589] [PMID:  35497948]

[9]
Gupta A, Al-Tamimi AO, Halwani R, Alsaidi H, Kannan M, Ahmad F. Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19. Exp Biol Med  2022; 247(14): 1205-13.
 [http://dx.doi.org/10.1177/15353702221091990] [PMID:  35466734]

[10]
Veenhuis RT, Zeiss CJ. Animal models of COVID-19 II. Comparative immunology. ILAR J  2021; 62(1-2): 17-34.
 [http://dx.doi.org/10.1093/ilar/ilab010] [PMID:  33914873]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0118715265301701240416055502	Print ISSN 1871-5265
Publisher Name Bentham Science Publisher	Online ISSN 2212-3989

Infectious Disorders - Drug Targets

Some Zoonotic Antigens May Help Combat Unknown Pathogens: Forming the Puzzle from the Evidences in the COVID Era

Related Journals

Related Books